Vasculitis of the skin reduces quality of life.

Published Date: 13 May 2023

In general, survey participants reported having poor health-related quality of life (QoF), which was deemed to be more severe by a skin-specific instrument than by a general health-related QoF index.

Read Full News

Latest News

CAR T-Cell Therapy for Skin Diseases Near Approval

CAR T-cell therapy is expected to expand quickly across autoimmune skin diseases following an anticipated regulatory approval that might come as soon as this year.

Eczema and the Topical Steroid Withdrawal Controversy

Topical steroid withdrawal is a controversial topic. What matters is treating patients with compassion and supporting them in their decision to stop treatment.

MCC Linked to Higher Mortality, Healthcare Use

Patients with Merkel cell carcinoma had higher mortality, more hospitalizations, and a greater comorbidity burden than matched patients without the disease and several other cancer cohorts in a study.

Judge Blocks Colorado's First-of-its-kind Price Cap on Amgen's Enbrel

A federal judge on Wednesday blocked Colorado from capping the price of Amgen's blockbuster arthritis drug Enbrel, a first-of-its-kind move ⁠by a U.S. state.

Androgenetic Alopecia Often Missed in Teens

Androgenetic alopecia is the most common form of hair loss in adolescents but often goes unrecognized even as new treatments are emerging for other forms of alopecia.

Influencers & UV Misinformation: What Can Dermatologists Do?

Misinformation about sun exposure and alternative tanning methods abounds on social media. What can dermatologists do to keep people safe?

Todays Updates

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Adjuvant Combination for Kidney Cancer Gets FDA's Blessing

Belzutifan and pembrolizumab together reduced the risk of disease recurrence or death

FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting

Capivasertib plus abiraterone combination lands indication for PTEN-deficient tumors

Talquetamab Regimens Boost Survival in Multiple Myeloma

"Combinations represent additional options for early-line treatment," researcher says

In High-Risk B-Cell ALL, Swapping Out Chemo for Blinatumomab Improves Outcomes

The bispecific T-cell engager also reduced toxicity in newly diagnosed kids

Timely 'Nudges' Can Help Encourage More End-of-Life Conversations in Cancer

A combination of clinician and patient prompts worked best, but talks remained infrequent

Todays Updates

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Adjuvant Combination for Kidney Cancer Gets FDA's Blessing

Belzutifan and pembrolizumab together reduced the risk of disease recurrence or death

FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting

Capivasertib plus abiraterone combination lands indication for PTEN-deficient tumors

Talquetamab Regimens Boost Survival in Multiple Myeloma

"Combinations represent additional options for early-line treatment," researcher says

In High-Risk B-Cell ALL, Swapping Out Chemo for Blinatumomab Improves Outcomes

The bispecific T-cell engager also reduced toxicity in newly diagnosed kids

Timely 'Nudges' Can Help Encourage More End-of-Life Conversations in Cancer

A combination of clinician and patient prompts worked best, but talks remained infrequent

Latest News

CAR T-cell therapy is expected to expand quickly across autoimmune skin diseases following an anticipated regulatory approval that might come as soon as this year.

Topical steroid withdrawal is a controversial topic. What matters is treating patients with compassion and supporting them in their decision to stop treatment.

Patients with Merkel cell carcinoma had higher mortality, more hospitalizations, and a greater comorbidity burden than matched patients without the disease and several other cancer cohorts in a study.

A federal judge on Wednesday blocked Colorado from capping the price of Amgen's blockbuster arthritis drug Enbrel, a first-of-its-kind move ⁠by a U.S. state.

Androgenetic alopecia is the most common form of hair loss in adolescents but often goes unrecognized even as new treatments are emerging for other forms of alopecia.

Misinformation about sun exposure and alternative tanning methods abounds on social media. What can dermatologists do to keep people safe?

News All Time

US FDA Reverses Course on Regenxbio's Rare-disease Gene Therapy, Backs Accelerated Approval Bid

Regenxbio said on Monday the U.S. FDA has indicated that existing data for its rare-disease gene therapy could support ⁠an accelerated approval application, reversing course...

Geographic and Income Data Missing From Cancer Trial Reports

Researchers conducted a systematic review of 441 US-based randomized cancer treatment trials to see what patient characteristics were reported.

Can Printed ‘Skin’ Help to Heal Burns Without Scars?

Inks created with a patient’s own cells may one day help the body regrow tissues.

Nicotinamide Cost-Effective for Reducing KC Risk

The study in US veterans found that oral nicotinamide was 'a cost-effective and patient-centric preventive approach' for keratinocyte carcinoma (KC), the study authors reported.

Down Syndrome: Skin Conditions That Demand Attention

Psoriasis, hidradenitis suppurativa, alopecia areata, and other skin conditions are more common in people with Down syndrome and require multidisciplinary, mechanism-specific management, experts say.

Barcelona Cases Point to an Emerging Transmissible Dermatosis

Ten confirmed cases in Barcelona suggest that a rare skin infection may be spreading through sexual networks, prompting earlier recognition and coordinated surveillance.

FDA Approves Hyaluronic Acid Filler for Reducing Neck Lines

A hyaluronic acid injectable product previously approved for cheek smoothing gets a new indication for reducing horizontal neck wrinkles.

Is Hidradenitis Suppurativa More Than a Skin Disease?

New evidence highlights genetic, metabolic, and immune drivers of hidradenitis suppurativa, supporting more coordinated care across specialties.

Surgical Plume Prevalent but Safety Protocols May Be Lacking

Surgical plume exposure occurs frequently for clinicians who perform laser-based procedures, but a new study suggests there is a lack of awareness of specific hazards.

How Blood Transfusion Became Safer

A practice once driven by hopes of restoring life and vitality is now a high-precision therapy where every unit of blood must be matched, tested, and traced.

Are Drug‑Resistant Infections Outpacing Industry Efforts?

High-quality research and proper antimicrobial stewardship can hold the key to mitigating antibiotic resistance.

Vulvar Melanoma Outcomes Worse With Surgery Delay

Surgical delays of 91 days and longer from diagnostic biopsy are linked to positive margins and worse survival in patients with early-stage vulvar melanoma, study finds.

Elicio Shares Slide After Pancreatic Cancer Vaccine Falls Short in Mid-stage Study

Elicio Therapeutics shares fell about 72% on Monday after the biotech firm's experimental pancreatic cancer vaccine ⁠failed to significantly extend the time patients lived...

Cutaneous Lupus Flares Peak During Late Perimenopause

Cutaneous lupus flares increase during late perimenopause and remain elevated after menopause, study finds.

Social Media Sunscreen Recipes Raise Safety Concerns

Homemade sunscreen recipes are gaining attention, but laboratory studies suggest they may reduce ultraviolet damage unevenly and fail against key sunburn markers.

Somatic Cancer Symptoms May Be Overattributed to Depression

Experts offer advice for treating symptoms of ovarian, breast, and other cancers that are not driven by depression and explain why it’s essential to discern the difference.

Recommended News For You

According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.

FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma

Smart exercise planning could boost recovery for people with cancer

Alternative Medicine for Breast Cancer: Study Raises Concern

Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL

Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit

Patients with head and neck cancer who cannot receive cisplatin now have new hope.

Recommended Articles For You

Clinical Methods in Hematology and Quality Improvement 

Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection 

Gene Therapy for Hemophilia: A New Hope on the Horizon 

Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Inner Thoughts of Leonard Bernstein, the "Maestro".

2.

Mobile prostate cancer screening clinic can ID the disease in disadvantaged men

3.

No Survival Benefit Seen With Adjuvant Atezolizumab in TNBC

4.

Parents, teachers at Missouri school want answers after string of cancer diagnoses

5.

A promising medication could slow brain tumors in children.

1.

Future-Ready Cancer Screening: What Every Clinician Should Know in 2025

2.

Cancer Evolution and Therapeutic Resistance: Mechanisms, Clinical Insights, and Emerging Strategies

3.

Targeting Cancer Stem Cells in Solid Tumors: Mechanisms, Clinical Implications, and Therapeutic Advances

4.

Partial Gland Ablation in Prostate Cancer: Oncologic Outcomes in Intermediate-Risk Cases

5.

Generative AI for Adaptive Oncology Trial Design

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC

4.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

5.

Current Scenario of Cancer- The Incidence of Cancer in Men

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot